(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -25.20%448.01M | 16.75%1.24B | --598.96M | 79.10%1.07B | 64.95%228.87M | 75.81%595.29M | 130.25%277.63M | --138.75M | 34.93%338.6M | --120.58M |
Operating income | -25.20%448.01M | 16.75%1.24B | 598.96M | 79.10%1.07B | 64.95%228.87M | 75.81%595.29M | 130.25%277.63M | 138.75M | 34.93%338.6M | 120.58M |
Cost of sales | 19.89%-322.77M | -19.05%-824.01M | ---402.9M | -64.89%-692.16M | -53.34%-155.59M | -79.47%-419.77M | -121.07%-194.22M | ---101.46M | -33.18%-233.89M | ---87.86M |
Operating expenses | 19.89%-322.77M | -19.05%-824.01M | -402.9M | -64.89%-692.16M | -53.34%-155.59M | -79.47%-419.77M | -121.07%-194.22M | -101.46M | -33.18%-233.89M | -87.86M |
Gross profit | -36.12%125.24M | 12.49%420.72M | 196.06M | 113.08%374M | 96.54%73.28M | 67.63%175.52M | 154.89%83.41M | 37.29M | 39.00%104.7M | 32.72M |
Selling expenses | -49.58%-8.7M | -41.96%-19.31M | ---5.82M | 0.58%-13.6M | 16.61%-3.13M | -88.54%-13.68M | -133.78%-6.43M | ---3.76M | -32.99%-7.26M | ---2.75M |
Administrative expenses | -41.50%-27.73M | -49.38%-49.58M | ---19.59M | -52.87%-33.19M | -135.96%-5.58M | -151.46%-21.71M | -290.22%-9.9M | ---2.36M | -47.69%-8.63M | ---2.54M |
Research and development expenses | 49.15%-14.35M | -5.60%-51.18M | ---28.22M | -123.31%-48.47M | -22.60%-8.15M | -44.24%-21.7M | -9.48%-9.01M | ---6.65M | -31.69%-15.05M | ---8.23M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -1,453.06%-21.08M | ---19.14M | ---8.7M | ---1.36M | ---- |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -1,453.06%-21.08M | ---19.14M | ---8.7M | ---1.36M | ---- |
Impairment and provision | 103.16%620K | -645.09%-30.18M | ---19.61M | -568.75%-4.05M | -107.11%-5.63M | 140.85%864K | 201.72%2.9M | ---2.72M | 37.72%-2.12M | ---2.85M |
-Other impairment is provision | 103.16%620K | -645.09%-30.18M | ---19.61M | -568.75%-4.05M | -107.11%-5.63M | 140.85%864K | 201.72%2.9M | ---2.72M | 37.72%-2.12M | ---2.85M |
Special items of operating profit | 3.06%1.92M | 124.81%6.03M | --1.86M | -178.84%-24.29M | -126.00%-1.42M | -536.37%-8.71M | 12.40%2.14M | ---627K | 893.03%2M | --1.9M |
Operating profit | -38.24%77M | 10.42%276.5M | 124.68M | 179.78%250.4M | 295.86%49.38M | 23.80%89.5M | 140.83%43.97M | 12.47M | 46.33%72.29M | 18.26M |
Financing cost | -22.12%-2.57M | -48.23%-4.83M | ---2.1M | -38.18%-3.26M | -9.74%-552K | -22.76%-2.36M | -36.06%-1.11M | ---503K | -81.82%-1.92M | ---818K |
Earning before tax | -39.27%74.44M | 9.92%271.67M | 122.58M | 183.61%247.14M | 307.88%48.83M | 23.83%87.14M | 145.75%42.86M | 11.97M | 45.56%70.37M | 17.44M |
Tax | -75.08%-10.96M | 26.68%-7.74M | ---6.26M | 31.59%-10.55M | -281.40%-10.62M | -52.42%-15.42M | -344.44%-8.92M | ---2.79M | -56.47%-10.12M | ---2.01M |
After-tax profit from continuing operations | -45.43%63.47M | 11.56%263.94M | 116.32M | 229.89%236.59M | 315.90%38.21M | 19.03%71.72M | 119.91%33.94M | 9.19M | 43.87%60.25M | 15.43M |
Earning after tax | -45.43%63.47M | 11.56%263.94M | 116.32M | 229.89%236.59M | 315.90%38.21M | 19.03%71.72M | 119.91%33.94M | 9.19M | 43.87%60.25M | 15.43M |
Minority profit | ---- | 98.04%-3K | ---3K | -110.09%-153K | -113.37%-73K | 10.81%1.52M | 235.74%883K | --546K | --1.37M | --263K |
Profit attributable to shareholders | -45.43%63.47M | 11.49%263.94M | 116.32M | 237.24%236.75M | 343.03%38.28M | 19.22%70.2M | 117.90%33.06M | 8.64M | 40.60%58.88M | 15.17M |
Basic earnings per share | -45.31%0.035 | -1.35%0.146 | 0.064 | 184.62%0.148 | 257.14%0.025 | 6.12%0.052 | 0.007 | 40.00%0.049 | ||
Diluted earnings per share | -1.35%0.146 | 184.62%0.148 | 6.12%0.052 | 0.007 | 0.049 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data